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ABSTRACT
This investigation was conducted to study the effects of acetaminophen on sulfur constituents in livers of rats fed various diets
differing in respect to inorganic sulfate and methionine. Sodium 35 so
was administered to label ester sulfates, 35 s-cysteine to label ester
sulfates and neutral sulfur compounds other than methionine and 35 s-

=

4

methionine to label ester sulfates and neutral sulfur and by a precursor
relationship give an indication of the effect acetaminophen may have on
the remethylation pathway.

Times of isotope injections were varied so

that i miiled i ate synthesis of sulfur compounds could be evaluated as ~.ie 11
as the effect the drug may have on tissue levels of sulfur compounds.
Results from this investigation demonstrate that:

(1) in acetaminophen-

treated rats, liver sulfate is lowered to some constant level at which sulfate conjugation becomes rate limiting; (2) methionine is possibly drawn
out of the remethylation pathway for synthesis of glutathione and cysteine;
(3) inorganic sulfate may spare cysteine and possibly has the potential

to inhibit the conversion of methionine to cysteine; and (4) inorganic
sulfate fed at the 0.02% level with methionine supplementation is the
optimal level which allows the liver to pull cysteine to glutathione
for detoxication of acetaminophen.

This investigation demonstrated the

need for dietary inorganic sulfate as well as sulfur amino acids for

acetaminophen detoxication, and that dietary levels of inorganic sulfate
can inhibit or enhance the effect exerted by the drug depending on the
level of inorganic sulfate and methionine.
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CHAPTER I
INTRODUCTION
Sulfur should be present in the diet of many organisms in the
form of organic as well as inorganic compounds.

The importance of inor-

ganic sulfur as a dietary constituent has been demonstrated in the laboratories of the r~utrition and Food Sciences Department, The University
of Tennessee at Knoxville, in the areas of carbohydrate, fat, and protein metabolism as well as for detoxication (1).

Organic sulfur in the

forms of glutathione, cysteine, and methionine are involved in many
physiological processes, but is especially important for the detoxication of xenobiotics such as acetaminophen.
Acetaminophen is a common, widely used analgesic that is a component of many over-the-counter preparations.

Atetaminophen has been

shown to be hepatotoxic to those who are frequent users, those who have
a history of liver disease, as well as those who have tried suicide by
its ingestion.

The drug's metabolism--although complex--requires inor-

ganic sulfate as well as organic sulfur.

Inorganic sulfate is mainly

used for sulfation while the sulfur nucleophile glutathione (cysteine
and methionine sulfur can be incorporated into glutathione) conjugates
the toxic metabolite which is generated through the cytochrome P-450
system.
sis.

This toxic metabolite, if not cleared, results in liver necro-

Not only is there a relationship between cysteine, methionine, and

glutathione, but cysteine can be the sulfur source for inorganic
sulfate.

2
Little information is available concerning the intricacies
dietary inorganic sulfate and methionine supplementation may have on
acetaminophen detoxication.

It is the purpose of this investigation to

provide evidence that dietary manipulation, through varying levels of
inorganic sulfate and methionine, will be able to alter the rat's ability to detoxify acetaminophen given as a pulse dose.

CHAPTER II
REVIEW OF LITERATURE
I. IMPORTANCE OF INORGANIC SULFATE
In the Monogastric Animal
Research has clarified the importance of inorganic sulfate to
the nutrition of the monogastric animal, particularly in reference to
carbohydrate, fat, and protein metabolism; drug detoxication; and tissue
integrity (1).

Wellers et al. (2) showed that inorganic sulfur in the

aiet could supply about one-third of the sulfur required beyond that of
amino acids.

Fulton and Smith observed that rats fed diets with vari-

able sulfate/sulfur ratios sho\,ed different responses to avitaminosis E
and that vitamin E deficient rats appeared to be less effective in converting 35 s-cysteine to 35 sulfate than vitamin E sufficient rats (3).
In studying the utilization of calcium and sodium sulfate by the rat,
Button et al. (4) demonstrated that dietary inorganic sulfate was well
absorbed and utilized for the formation of mucopolysaccharides.

Michels

and Smith (5) showed that, unless the requirement for sulfur-containing
amino acids is to be increased, the diet must contain a minimal amount
of inorganic sulfur.

Brown and Gamatero (6) showed that addition of

inorganic s~lfur to the diets of rats fed an inadeq~ate protein source
low in sulfur containing amino acids improves net weight gain, feed:gain
ratios, and protein efficiency ratios.
Researchers have shown that a lack of inorganic sulfate in the
diet forces the rat to satisfy its sulfate requirements by the oxidation
3

4

of cysteine to sulfate, which is a wasteful process.

Whittle and Smith

(7) demonstrated that rats fed diets low in inorganic sulfur excrete
twice as much cysteine sulfur as taurine sulfur compared with those
animals fed diets high in inorganic sulfur.

This observation agrees

with that of Michels and Smith (5) that diets low in inorganic sulfur
appear to raise the methionine requirement of the rat.

Although the

increased excretion of taurine may not be harmful, other deleterious
effects appear to be associated with forcing a rat to supply its sulfate
needs by oxidation of cysteine sulfur.

For example, Fulton and Smith (3)
demonstrated that avitaminosis E reduced the incorporation of 35 s-sulfate
by cellular lipoprotein and by the sulfolipid and mucopolysaccharide
fractions associated with the lipoprotein.

From the work of Brown et

al. (8) it is demonstrated that a decrease occurs in the breaking
strength of the aorta of rats fed diets low in sulfate.

In addition,

when rats from mothers fed a low-sulfate diet were transferred to a low
sulfate diet without cod-liver oil, gross malformation of the hind limbs
was seen (1).
Smith has established the optimal level of inorganic sulfate in
the diet of a rat to be 0.02% (9).

Smith and his coworkers also have

shown that dietary sulfate levels both above ana helow this opti~al
level result in changes in glycogen storage, and in the activity of rat
liver phosphoenolpyruvate-carboxykinase, pyruvate carboxylase, 1 changes in
the activity of propionyl-CoA carboxylase, 2 acetyl-CoA carboxylase, citrate
1Feland, B., Disney, G. W. & Smith, J. T. (1973) Dietary sulfate
as a metabolic regulator. Fed. Proc. 32:883.
2white, V. & Smith, J. T. (1575) Effects of inorganic sulfate on
propionyl-CoA carboxylase. Am. Chem. Soc. Southeast Regional Me2ting
1:225.
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cleavage enzyme, malic enzyme, 3 glutamyl transferase, 4 coenzyme A conh

centration,~ the number of lung lesions formed from intratracheal
instillation of benzo(a)pyrene, 6 and the ratio of salicylarnide:sulfate
excreted in the urine. 7
Following the work of Wnit~le and Smith (7) the effect of dietary
inorganic sulfur on the relative concentration of taurocholic and glycocholic acids in the s~all intestine was measured.

Earlier investiga-

tors (10) had shown that in man the glycocholic:taurocholic acid ratio
is a reflection of the availability of taurine.

Therefore, based on

Wnittle's and Smith's data, those rats fed the diet containing 0.0002%
sulfate should have had the smallest intestinal glycocholic:taurocholic
ratio.

However, those rats fed the diet containing 0. 1% sulfate had a

significantly lower glycocnolic:taurocholic ratio than those fed diets
either low or high in sulfate.

Since a low glycocholic:taurocholic

ratio is generally correlated with low serum cholesterol levels, serum
3
Bittle, J. B. &Smith, J. T. (1975) Effect of dietary inorganic
sulfate on selected enzymes of lipogenesis in the rat. Fed. Proc.
36:1114.
4Nielson, R. L. & Smith, J. T. (1975) Effect of dietary sulfur on
glutathione concentration and y-glutamyl transferase activity in the rat
brain. Fed. Proc. 37:752.
5
Smith, J. T. & Verma, R. S. (1974) Relative conjugation of Qlycine
and taurine with cholic acid by rat liver microsome preparation. rea.
Proc. 33:689.
6
settle, E. A. (1977) An investigation of the relationship between
sulfur nutritional status and lung neoplas~s induced by oenzo(a)µyrene
in rats. Unpublished Ph.D. dissertation, The University of Tennessee,
Knoxville.
7
Kurzynske, J. S. & Smith, J. T. (1975) A relationship between the
dietary history of a rat and the relative conjugation of glucuronate and
sulfate with salicylamide. Fed. Proc. 34:882.

6

cholesterol levels and blood glucose levels nave been detercined in rats
fed these diets with different inorganic sulfate levels and different
levels of cysteine supplementation.

The glycocholic:taurocholic acid

ratio, serum cholesterol, and blood glucose levels were interrelated and
related to the sulfur nutritional status in the rat (ll).
In Drug Metabolism
Inorganic sulfate has also been shown to have a role in drug
detoxication.

Roe (12) demonstrated that indole-fed rats could use

inorganic sulfate as an efficient source of sulfate ions for indican
formation.

Moldeus et al. (13) showed that sulfate conjugation of

harmol and acetaminophen in isolated hepatocytes was highly dependent on
extracellular

so 4-.

Weitering et al. (14), by measuring the sulfate and

glucuronide conjugates in vivo, studied the depletion of the inorganic
sulfate pool in rats after administration of phenol.

Data indicated

that with increased dose of phenol its glucuronidation increases relative to its sulfation but that this switch over is not due to a rate
limiting supply of inorganic sulfate for sulfotransferases but perhaps
to a higher Km for the for~ation of 3'phosphoade~osine-5'-phosp~osulfate
Slattery and Levy (15) were able to demonstrate that Na 2so 4
significantly decreased the Lo 50 of acetaminophen relative to that with
(PAPS).

NaCl administration.
In conclusion the inorganic sulfur status is important in carbohydrate, fat, and protein metabolism; tissue integrity; and drug detoxication in the monogastric animal.
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II.

METABOLISM OF ACETAMINOPHEN

Acetaminophen, widely used as an antipyretic and analgesic, is
found in over 200 formulas (e.g., Tylenol, Comtrex, Excedrin, Nyquil,
Under normal therapeutic doses acetaminophen is primarily

Vanquish).

metabolized by conjugation with glucuronide or sulfate with a plasma
half life range of 1-3 hours (16).

Sulfate conjugation is the preferred

route of metabolism but as the dose and concentration of the drug
increase so does the formation of a
18, 19).

glutathione (GSH) conjugate (17,

Early evidence by Jollow and his coworkers indicates that when

the GSH pools are 80% or more depleted a toxic metabolite is formed via
the microsomal P-450 mixed function oxidase system; this metabolite
combines with liver microsomal proteins and causes necrosis (20, 21, 22).
More recent research indicates that the toxic ~etabolite is N-acetyl-pquinoneimine (23, 24).
seen in fig. l (25).

An overview of acetaminophen metabolism can be
Although ~any believe that necrosis results from

the binding of a toxic metabolite to liver protein, others feel that
necrosis is a result of lipid peroxidation (26, 27).
Acetaminophen is passively absorbed from the gastrointestinal
tract (28).

Heading et al. demonstrated that the rate of gastric

emptying influenced plasma concentration and urinary excretion (29).
Acetaminophen ingestion also has been associated with nephropathy
(1, 30).

Acetaminophen is metabolized primarily by the liver but the

kidney does convert the GSH conjugate to the mercapturic acid derivative (31).

Porter et al. (32) showed that acetaminophen slowed mito-

chonarial respiration by inhibiting electron transport between NADH
dehydrogenase and cytocnrome b.

The requirements for GSH synthesis by

8
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HNCOCH 3
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Metabolism of acetamlnophen.1

Wolff, M. ed. ( 1980) Burger's Medic al Chemistry.
Part 1. The Basis of Medicinal Chemistry. 4th
ed. John WIiey & Sona, New Vork.
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kidney cells are different from tnose for liver cells in that the
y-glutamyl cycle functions in the kidney (33).
Glutathione synthesis, concentration, and availability are major
factors or concerns in acetaminophen metabolism and will be diagramed
later.

Higashi et al. (34) suggest that there might be two GSH pools

but Lauterburg's recent probe analysis technique discredits this interpretation (35).
The toxic metabolite is believed to be generated through the
P-450 mixed function oxidase system (36).

Therefore, any drug or proce-

dure that influences this system also has the potential to affect the
metabolism or efficacy of acetaminophen.

Acetaminophen, although a

structurally simple compound, possesses a multifaceted metabolic pathway.
III. SULFUR METABOLISM IN RELATION TO
ACETAMINOPHEN DETOXICATION
Smith (l) offers a schematic representation of the metabolic
pathways leading to the formation of sulfate from the sulfur-containing
amino acids methionine, cysteine, and cystine.

Since in low doses

acetaminophen is sulfated it is important to understand the formation of
PAPS.

At higher doses of acetaminophen an active metabolite is conju-

gated by GSH and when GSH is depleted necrosis will result.

It is

therefore important to understand metabolism and sulfur sources of
glutathione (fig. 2).
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ACETAMINOPHEN HEPATOTOXICITY
Researchers in different disciplines have been searching for
clues to the biochemical mechanisms involved in the metabolism of
acetaminophen, the mechanism(s) of liver necrosis, and the management
of acetaminophen in therapeutic and toxic doses.

As outlined in the

previous section the metabolism of acetaminophen is complicated, but it
is generally conceded that necrosis results from the microsomal cytochrome P-450 mediated oxidation of the analgesic which becomes bound to
~icrosomal liver protein when GSH pools are depleted (16, 37).
Morphological Changes in the Liver
The biochemistry of acetaminophen-induced hepatotoxicity has been
extensively investigated but the exact mechanisms of cell necrosis have
not been elucidated.

Dixon et al. (38) working with rats killed at differ-

ent times after toxic doses, summarize the events of hepatotoxicity as
follows:

hydopic vaculation, centrilobular necrosis, macrophage infil-

tration, and regenerative activity with rapid restoration to normal.
Studying the morphology of acetaminophen induced necrosis has led some
investigators to suggest the toxicity to be a result of structural
damage to the endoplasmic reticulum as manifested by lipoperoxidation
and reduced activities of microsomal enzymes (39).

Recently, Walker

and his colleagues embarked on a detailed electron microscopy study and
discussion of acetaminophen induced hepatotoxicity (40).
Factors Affecting Acetaminophen Metabolism
There can be many factors that can inhibit or induce the action
of acetaminophen.

Different rates of metabolism or toxicity can be
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observed with respect to:

age, propylthiouracil (PTU)-induced hypothy-

roidism, diabetes, ascorbic acid, previous liver status, fasting, and
drugs.
The variable of age and its effect on acetaminophen metabolism
and hepatotoxicity has been documented in rats, mice, and humans.
Peterson and Rumack (41) report that of among 416 patients studied, the
16 children under five years of age had a relatively low incidence of
toxicity as compared with the adult group.

This could be attributed

to a change from predominantly sulfate to glucuronide metabolism, and/
or an immature P-450 system to make the reactive metabolite (42, 43).
The Levy et al. study indicated that neonates were able to metabolize
acetaminophen well because a limited ability to conjugate the drug with
glucuronic acid was compensated by sulfate conjugation (44).

Several

investigators tested the hyµothesis that young mice or rats are less
susceptible to acetaminophen overdoses than older animals (45, 46).
Results from these studies indicate less covalent binding of acetaminophen to liver protein, less hepatic GSH depletion, and less hepatic
necrosis in young than in adult animals.

The reason given for this

phenomenon is that the young animals have an immature hepatic mixed
function oxidase system which would theoretically reduce the amount of
toxic metabolite formed.

The data of Alhava et al. are not in agreement

with the other research results outlined, but this could be due to
different strains and species of animals (47,22).
Linscheeret al. proposed that PTU-induced hypothyroidism would
protect against acetaminophen toxicity; the proposal was based on evidence that hypothyroidism increases red cell glutathione levels and PTU
may act as a substrate for GSH (48).

Their blood evaluation and

14

electron microscopy revealed less toxicity, probably because of
increased GSH levels or increased glucuronidation of acetaminophen.
Another endocrine disorder that alters acetaminophen metabolism
is diabetes (49).

Research with streptozotocin diabetic rats indicates

that the diabetic rats are more susceptible for acetaminophen to deplete
GSH levels than controls.
Ascorbic acid is partly converted to ascorbic acid sulfate in
humans (50).

This finding induced Houston and Levy to determine whether

3 g of ascorbic acid would have an effect on the metabolism of l g
acetaminophen in male volunteers (51 ).

Results indicated that ascorbic

acid caused a significant decrease in the fraction of acetaminophen
excreted as sulfate and increased the fraction excreted as glucuronide
but had no effect on the recovery of total acetaminophen.

After the

administration of ascorbic acid there was a decreased excretion rate
of acetaminophen; the decrease could be inhibited by sodium sulfate but
not L-cysteine.

The authors suggest that individuals ingesting mega-

doses of vitamin C while on acetaminophen therapy should be evaluated
for susceptibility to liver necrosis, especially if there already exists
some liver condition.
Animal and human research indicates that a liver is more susceptible to hepatotoxicity if there is an existing liver condition or
chronic alcohol consumption (52, 53, 54).

Another study with rats

revealed that a single dose of ethanol protects against acetaminophen
hepatotoxicity (55).

A case study reported by Bonkowsky et al.

describes chronic hepatic necrosis in a 53-year-old man who had taken
4 g of acetaminophen a day for l year (56).

l5

There have been numerous reports concerning the effects of
fasting, different diets, and drug therapy, alone and in combination,
on acetaminophen toxicity and metabolism (57, 58).

Jaffe

et al.

studied acetaminophen absorption in man and found that neither a high
lipid content, high protein content, or a balanced meal had any effect
on the drug's excretion but fasting did result in higher excretion
values (59).

Other researchers have demonstrated that fasting will

increase hepatotoxicity due to decreasing GSH levels (60, 61.).

Work

with the effect of other drugs given simultaneously with acetaminophen
showed an increased hepatotoxicity, with some drugs depleting GSH levels
or sulfate levels or inducing the mixed function oxidase system (62, 63,
64).

In summary, there are many factors in acetaminophen administration

that have the potential to alter, inhibit, or induce the metabolism and
hepatotoxicity of acetaminophen.
Treatment of Hepatotoxicity
Davidson and Eastham reported the first case of acetaminophen
induced hepatic necrosis in humans in 1966, 70 years after the drug's
introduction (65).

Because of its accessibility and popularity, the

United Kingdom and the United States have had to deal with the problem
of treating hepatotoxicity mainly as a consequence of suicide attempts.
Treat@ents have included attempts to reduce the gastrointestinal tract's
absorption of the drug by the administration of charcoal or cholestyramine, enhance removal from plasma by hernodialysis, or by charcoal hemoperfusion; however, none of these methods seemed adequate (16).
In approaching the problem of treating hepatotoxicity, researchers have looked at it in terms of providing chemical sources which act

16
as surrogate glutathione or inhibit the cytochrome P-450 mixed function
oxidase enzymes.

A closer look at these two avenues of research reveals

conflicting, even confusing data.
For example, N-acetyl cysteine is considered the antidote of
choice (16, 66, 67); it possibly acts to replenish glutathione but the
mechanism has not been proven.

Whitehouse et al. claims that N-acetyl

cysteine inhibits gastric emptying (68).

Vina et al. claim that large

doses of N-acetyl cysteine decrease hepatic GSH levels while still
protecting against hepatotoxicity; others just report that it works but
they do not offer any explanations for their data (69, 70, 71 ).
McLean and Day showed that adding 10% methionine to their low
protein and/or phenobarbital

treated rats would protect against hepato-

toxicity by supplying the needed glutathione (72).

Buckpitt et al.

investigated the effect of glutathione, cysteine, N-acetyl cysteine,
cysteamine, cr-mercaptopropionylglycine, and methionine on the NADPHdependent metabolism and on covalent binding of acetaminophen.

They

concluded that methionine did not affect the covalent binding of acetaminophen (73).

This is in agreement with Labadarios et al. who suggest

that cr-mercaptopropionylg1ycine administration decreases hepatotoxicity
but not by binding the toxic metabolite itself.
pionylglycine acts like GSH

Rather, a-mercaptopro-

(74).

Since the metabolism of large doses of acetaminophen involves a
P-450 mediated toxic metabolite that binds to liver macromolecules and
causes necrosis, some investigators have thought of the possibility of
treating toxicity by inhibiting P-450 enzymes.

Metyrapone tartate

administered i.p. 400 mg/kg raised the Lo 50 for acetaminophen from
340 mg/kg i.p. to 540 mg/kg in fasted white mice (57 ). As previously

l7

mentioned, it has been shown that a single dose of ethanol (l g/kg) protects against hepatotoxicity in white mice presumably by depressing
P-450 levels (55).

Another study indicating that the depression of

P-450 levels can decrease hepatotoxicity of acetaminophen is that of
Strubelt et al. demonstrating that pretreatment with acetaminophen produces complete protection against further doses of acetaminophen (75).
The purpose of this investigation was to offer some insight into
the effect of acetaminophen and various levels of inorganic sulfate with
methionine supplementation on tissue levels and stores of ester sulfates
and neutral sulfur compounds.

This investigation was also an attempt

to provide information concerning the effect of acetaminophen and various levels of inorganic sulfur varying in methionine supplementation on
the remethylation pathway.

CHAPTER III
EXPERIMENTAL PROCEDURE AND METHODS
Rationale for Experimental Design
There are many factors that have the potential to alter, inhibit,
or induce the metabolism and hepatotoxicity of acetaminophen as discussed in Chapter l.

Sprague Dawley male rats were chosen for this

investigation because of their use in many of the studies discussed.
Age and maturity were controlled through the use of animals of 150-190 g.
However, in experiments l and 2, a limited supply of animals dictated
the use of 250-400 g rats.
Several routes of administration were investigated in the studies
described, but the stomach tube was chosen as the best method to mimic
normal therapeutic use.

Rats were fed up to the point of sacrifice in

order to avoid a fasting effect on results.

A low dosage was chosen in

order to mimic conditions that would be more representative of a therapeutic dose.

Experiments l, 3, and 5 were designed to study the effects

of acetaminophen on the liver's immediate sulfur metabolism; experi~ents
2, 4, and 6 were designed with a longer wait between injections of the
labeled sulfur source and killing in order to study the effect of the
detoxication of acetaminophen on tissue stores.
Groups of 30 male Sprague-Dawley rats were fed casein based semipurified diets containing either 0.0002%, 0.02% or 0.42% inorganic
sulfate.

The diets containing 0.0002% and 0.02% were supplemented with

methionine to provide constant sulfur while the 0.42% diet had no
methionine supplementation (Tables l and 2).
18

The animals were housed
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TABLE 1
Composition of the diets

Component

Quantity per 100 grams
.0002%S0 4=
.02%S0 4=
Diet A
Diet B
g
g

.42%S0 4=
Diet C
g

Casein

15.00

15.00

15.00

Sucrose

30.00

30.00

30.00

Cornstarch
Amphace 11

30.00

30.00

30.00

11 . 65

11 . 65

11 . 65

Cod 1i ver oil

2.00

2.00

2.00

Vegetable shortening
V1·t am. n m,. xt ure 2

6.00

6.00

6.00

2.00

2.00

2.00

Salt mix

1. 35

1.35

1.35

Caso 4

0.00

0.04

0.75

Caco 3

1. 34

1.32

0.91

Methionine

0.67

0.62

0.00

1Alphacel, Nutrition Biochemicals Corporation, Cleveland, Ohio
44128.
2Nutrition Biochemicals Corporation, Cleveland, Ohio 44128.
Vitamin Diet Fortification Mixture formulated to supply the following
amounts of vitamins (g/kg vitamin premix): thiamin hydrochloride 1.0,
riboflavin 1 .0, niacin 4.5, p-aminobenzoic acid 5.0, calcium pantothenate 3.0, pyridoxine hydrochloride 1 .0, ascorbic acid 45.0, inositol 5.0,
choline chloride 75.0, menadione 2.25, biotin 0.020, folic acid 0.090,
vitamin ~ 0.00135, ~-tocopherol 5.0, vitamin A 9 x 105 units, vitamin
D 1 x 10 12units, and sufficient glucose to make 1 kg.
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TABLE 2

Composition of salt mix

Component

Quantity per 500 g
g

MgC0 3

33.700

NaCl

77. 400

KCl

125.400

KHl0 4

237.800

FeP0 4 · 2(H 20) or (FeC 6H5o7 )
KI

23.000

NaF

0. l 00

MnC1 2 · 4H 20
AlK·S0 4 · 12 H20
Cu(C 2H3o2 ) 2 · H20

0 .450
0. 019

ZnC0 3

4.800

0 .090

0.810
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in stainless steel group cages and fed these diets and distilled water
ad lib. for 17 days.

The radioactive sulfur source was dissolved in

saline so that each 0.5 ml contained 7 µCi.
of the radioactive saline solutions. c.

~ach rat was given 0.5 ml

The drug was prepared by dis-

solving 75 mg acetaminophen/kg body weight in 5 ml of corn oil and
administered by stomach tube.

Control animals were treated with the

labeled sulfur source and corn oil without acetaminophen.
Experiment l
To assess the effect of diet and acetaminophen on the synthesis
of ester sulfate compounds, rats were simultaneously given Na 235 so 4=
and acetaminophen. After the injections, the rats were housed in special isolated cages for radioactive animals and given their respective
diets and distilled water ad lib.

Three hours after the injections

the rats were decapitated and the livers were excised, placed in tared
vials, weighed, and stored at -20°c until analysis.
To prepare the livers for determination of radioactivity and
total sulfur analysis, the livers were lyophilized in a Virtis freeze
dryer.

The freeze-dried livers were pulverized with a stainless steel

spatula.
To determine specific activity duplicate 500-600 mg samples were
weighed and combusted in a Parr Bomb with 10 ml distilled water.

The

aqueous ash from each was transferred to a beaker whereupon the bomb container was rinsed with distilled water and contents emptied into the beaker
several times.

The aqueous ash extract was evaporated to dryness and

2 ml of distilled water were added.

Two 0.5 ml samples were pipetted

into scintillation vials to which 6 ml 2-ethoxyethanol and 10 ml of
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2,5-diphenyloxazole (12 gin l liter toluene) were added.

Radioactivity

was evaluated with a Beckman LS lOOC liquid scintillation system.
data were expressed as cpm/mg, cpm/mg. body weight, cpm/mg

f

The

dry liver

weight as% dose, total cpm as% dose. wet liver weight.
For total sulfur analysis 500-600 mg liver samples were combusted
in the Parr Bomb with 10 ml distilled water.

The aqueous ash from each

sample was transferred quantitatively to a 25 ml volumetric flask and
made to volume with distilled water.

Portions of the dilute ash were

analyzed in duplicate for total sulfur by a method described by Roe (76).
A standard stock solution was made by dissolving 1.479 g of sodium sulfate in 500 ml of distilled water which yielded a concentration of
2000 ppm of sulfate.

Al ml portion of dilute ash was added to a 50 ml

conical Pyrex centrifuge tube and l ml of 5% lanthanum chloride and 2 ml
of 15% barium chloride~were pipetted into each, sample.

A standard was

prepared with each sample set by mixing 0.25 ~, of the standard stock
solution with 0.75 ml distilled water, l ml of lanthanum chloride, and
2 ml of 15% barium chloride.

The samples were mixed with a Vortex mixer

and centrifuged at 2000 x g for 10 minutes in an International Harvester
Model SBV centrifuge.

The supernatant was decanted and the centrifuge

tubes were carefully dried with tissues to remove residual water.

Five

ml of distilled water were added to each precipitate, mixed, centrifuged,
and supernatant discarded.

After two additional washings the centrifuge

tubes were drained and dried and 10 ml of an alkaline disodium ethylenediamine solution (prepared by dissolving 10 g EDTA in 500 ml of distilled
water, adding 20 g of sodium hydroxide and diluting to 2000 ml) were
added.

Each sample was mixed thoroughly with a Vortex mixer.
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Samples and standards were aspirated into the fla~e of a Perkin
Elmer Model 303 Atomic Absorption Spectrophotometer equipped with a
barium hollow cathode tube operated at 20 milliamps.
settings were:

The instrument

monochro~eter, 276 nm visible; gain, 5 to 6; slit, 3;

flow rate of nitrous oxide, 8.5; flow rate of acetylene, slightly above
15.

The nitrous oxide burner was ignited and the fuel flow was adjusted

to give a characteristic magenta cone.

Percent absorption was recorded

and later converted to absorbance so that the µg sulfate per mg liver tissue
of mg combusted samples could be calculated by the following equations:
a)

b)

Absorbance of unknown
Concentration
Dilution
Absorbance of standard x Standard (ppm)x Dry weight of liver
= µg Sas so -; liver
4
Absorbance of unknown
Concentration
Dilution
Absorbance of standard x Standard (ppm) x g liver sample=

µg Sas so -; g tissue
4
The burner and aspiration assembly were cleaned after every 24 readings
to insure accuracy.
Experiment 2
This experiment was designed to measure the effect of diet on
detoxication of acetaminophen and on tissue stores of Na 235 so 4 labeled
sulfur sources. Experiment 2 differed from experiment l in that
Na 235 so 4 was given 24 hours prior to acetaminophen administration. The
methods of analysis were the same as in experiment 1.
Experiment 3
This experiment was designed to measure the effect of diet and
drug detoxication on synthesis and/or utilization of ester sulfate compounds and neutral sulfur compounds (glutathione, cysteine) and to

24
elucidate mechanisms in the methionine remethylation pathway. Labeled
35 s-methionine was injected simultaneously with acetaminophen; 3 hours
later the rats were sacrificed and livers were excised and placed in
20 ml 2% sulfosalycilic acid.

The livers were blenderized and centri-

fuged at 5000 x g for 15 minutes.

The supernate fluid was saved and

into each sample l ml each of glutathione, cysteine, and methionine was
pipetted to enable the recovery of the radioactive sulfur compounds.

The glutathione and cysteine solutions were made by dissolving separately in 10 ml volumetric flasks, 200 mg reduced glutathione and
cysteine.

Methionine was prepared in the same manner except that it

was dissolved with 0.02 N HCl instead of distilled water.
Following an adapted method of Mimura et al. (77) the solution
was eluted through a 45 x 2.5 cm Dowex-50 column first with 200 ml of
water then 200 ml of 0.05 N HCl.

After these solutions were eluted

l N HCl was added to the column.

By testing the eluate from the column

with a platinic iodide solution the presence of sulfur containing compounds could be detected.

Elution of glutathione and cysteine from the

column required approximately 400 and 600 ml respectively of l N HCl
solution.
HCl.

Elution of methionine required approximately 200 ml of 2N

These three different compounds were collected in beakers and

evaporated to dryness.

Earlier testing with paper chromatography tech-

niques revealed the relative purity of each of these compounds (78).
After evaporation to dryness 5 ml of distilled water were added
to each beaker.

Two 0.5 ml samples were used for counting in the

scintillation counter while two l ml samples were pipetted into 25 ml
Erlenmeyer flasks for titration against a platinic iodide solution.
The platinic iodide solution was prepared by combining 0.8 ml 10%
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platinum chloride, 124.2 ml distilled water, and 25 ml 6% potassium
iodide.

A titer for glutathione, cysteine, and methionine was deter-

mined after taking 0.1, 0.3, 0.5, and 0.7 ml of a solution of 200 mg of
the compound dissolved in 10 ml of distilled water--except in the case
of methionine where it was dissolved and brought up to volume with 0.02

N HCl.
Data were expressed in terms of% dose, % dose+ liver weight,
and% dose+ body weight for each 35 s-sulfur compound recovered.
Experiment 4
This experiment was designed to measure the effect of diet and
drug detoxication on tissue utilization of ester sulfates and neutral
sulfur compounds and the effect on the methionine remethylation pathway
with the injection of 35 s-methionine. Experiment 4 differed from
experiment 3 in that acetaminophen was administered three hours after
35 s-methionine. Three hours after acetaminophen administration the
animals were sacrificed and the same procedure and analysis as described
for experiment 3 were performed.
Experiment 5
To determine the effect of diet and drug detoxication on the
synthesis of sulfur compounds, 35 s-cysteine was given simultaneously
with acetaminophen to label ester sulfate and neutral sulfur compounds
other than methionine.

Rats were sacrificed three hours after the

injections and the same procedure as described for experiment 3 was
performed except that methionine was neither added to the liver
solution or collected.
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Experiment 6
This experiment was designed to measure the effect of diet and
acetaminophen detoxication on tissue synthesis of ester sulfates and
neutral sulfur when given a 35 S-cysteine· source. This experiment differed from experiment 5 in that acetaminophen was administered three
hours after 35 s-cysteine. Three hours after acetaminophen was administered the rats were sacrificed and the same procedure as in experiment 3
was performed.
Statistical Methods
Data were analyzed to determine the statistical significance of
results by the method of paired comparisons as described by Steele and
Torrie (79).

CHAPTER IV
RESULTS
Experiment l: Rats Injected with 35 so 4= Si~ultaneously with Acetaminophen Administration
The data showing the interrelationship among dietary inorganic
sulfate, varying levels of methionine, acetaminophen administration, and
total sulfur as sulfate content of rat liver as% body weight are seen
in Table 3.

A statistically significant difference in total liver sul-

fur as sulfate was observed between control rats fed diets containing
0.0002% inorganic sulfate supplemented with methionine and livers from
rats fed 0.42% inorganic sulfate without additional methionine--the latter
having the lower value. There was no detected difference among acetaminophentreated rats fed the various diets.

The effect of acetaminophen in

lowering total liver sulfur as sulfate was statistically signficant
with diets containing the 0.0002% and 0.02% inorganic sulfate with
methionine supplementation but not when compared to the rats fed the
diet containing 0.42% inorganic sulfate with no additional methionine.
Although the contrcl group fed the 0.42% inorganic sulfate without additional
methionine did not have a statistically significant difference in total
liver sulfur as sulfate when compared to the acetaminophen-treated
group, it did have a higher total sulfur as sulfate content in the liver.
· re f erence t o 35 s-ra d.,oac t.,v,. t y ( Ta bl es
Wh en dat a are expresse d ,n
4 and 5) the dietary level of inorganic sulfate did not affect the
values regardless of acetaminophen administration or when expressed as
cpm/mg, cpm/mg + body weight, cpm/mg x dry liver weight, and total cpm +
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TABLE 3
An interrelationship between dietary inorganic sulfate,
acetaminophen administration, and the sulfate content
of rat liver (Experiment l)

Dietary
Sulfate%

Total Liver Sulfate as% Body Weight
With Acetaminophen
Without Acetaminophen
X

.0002 (Diet A)

a*
15.2 ± 1.21,2,3,

.02 (Diet B)

15. 8 ± l. l

. 42 (Diet C)

a*
15. 3 ± 1.8

a*

l0- 2

2.8a,b

31.9

±

30. l

± l •3

21.3 ± 1.9

a' b

b*

1oata are means± SEM of 5 male rats.
2values in a column not followed by the same superscript letter
are significantly different (P : 0.05).
3values on a line not followed by the same superscript symbol are
significantly different (P < 0.05).

TABLE 4
The effect of dietary igorganic sulfate and acetaminophen administration on the
total
so = uptake in rat liver (Experiment l)
4
35 so4= Radioactivity in Dry Liver
With Acetaminophenl
Without Acetaminophen
cpr.1/mg
cpm/mg f body wt.
cpm/mg
cpm/mg f body ~~t.
X 10-b
X 10-5

Dietary
Sulfate%

.0002 (Diet A)

37.8 ± 5.5 2 , 3 , 4 a*

.02 (Diet B)

37.l

. 42 (Diet C)

4.9 a *
29. 9 ± l. 8a *
±

12. 7 a *
9.7 ± 1.2 a *
8.9 ± 0.9 a *

24. l

±

2. l a *
51.3 ± 2.5 a *
50.6 ± 8.4 a

39. 8

±

10.8 ± 1.4 a *
14.4 ± 1.3 a *
14.9 ± 3.2 a *

1Acetaminophen and Na 35so4= administered simultaneously.
2
2oata are means± SEM of 5 male rats.
3column values for identical computations not followed by the same superscript letter are significantly different (P < 0.05).
4Line values for identical computations not followed by the same superscript symbol are significcantly different (P < 0.05).

N
\.0

TABLE 5
The effect o~ die!ary inor~anic su~fate and acetaminophen adminis!ration on the
total 5so 4- uptake in rat liver expressed as% dose (Experiment l)

Dietary
Sulfate%

.0002 (Diet A)
.02 (Diet B)
. 42 (Diet C)

35 so11 = Rad_i_oact i vi ty in Dry Liver as Expressed By% Dose
With Acetaminophenl
Without Acetaminophen
cpm/mg x
total cpm +
cpm/mg x
total cpm +
dry liver v-1t.
wet liver wt.
dry liver wt.
wet live r wt.
X 10- l
X 10-4
X 10-l
X 10- 4
l . 52 ' 3 ' 4 a *
11 .3 ± 0.8 a *
7.9± 0.3 a *
11 . 2

±

1.4 a *
9.8 ± l .2 a *

9.8

7.9

±

±

0.4 a *

12.6

±

15.8

±

1.5 a*
1.8 a*

14.2 ± 1.2 a

10.5 ± 0.5 a*
13.4 ± 1.3 a*
13.4

±

2.0 a

1Acetarninophen and Na 35 so = administered simultaneously.
2
4
2Data are means± SEM of 5 male rats.
3column values for identical computations not followed by the same superscript letter are significantly different (P < 0.05).
4Line values for identical computations not followed by the same superscript symbol are significantly different (P < 0.05).

w
0
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wet liver weight.

There is a significant difference between the lower

values for acetaminophen-treated rats and the higher values for control
rats fed diets containing 0.42% inorganic sulfate with no methionine
supplementation when data are expressed as cpm/mg x dry liver weight and
total cpm + wet liver weight (Table 5).

No differences are seen between

diets in any of the data with respect to dietary levels of inorganic
sulfate or methionine supplementation when data are expressed as cpm/mg,
cpm/mg +bodyweight, cpm/mg x dry liver weight, and total cpm

+

wet

liver weight.
Experiment 2: Rats Injected with 35 so 4= Twenty-Four Hours Prior to
Acetaminophen Administration
An interrelationship among dietary inorganic sulfate, methionine
supplementation, and the sulfate content of rat liver can be seen in
Table 6.

The only effect of dietary sulfate as% body weight content is

detected in acetaminophen administered rats fed a diet containing a
0.02% inorganic sulfate with methionine compared to those rats fed a
diet containing 0.42% inorganic sulfate with no additional methionine.
A statistically significant difference in total sulfur as sulfate
between the livers of rats administered acetaminophen and the control
rats can be seen in only those rats fed the 0.02% level of inorganic
sulfate with methionine supplementation; the livers from rats given
acetaminophen had the higher total sulfur as sulfate content.
Tables 7 and 8 present the data expressed in terms of 35 so 4=
radioactivity. Control rats fed a diet containing 0.0002% inorganic
sulfate plus methionine have higher values of 35so 4= than treated rats
when expressed as: cpm/mg, cpm + body weight, cpm/mg x dry liver weight,
and total cpm

+

wet liver weight.

A statistically significant dietary
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TABLE 6
An interrelationship between dietary inorganic sulfate,
acetaminophen administration, and the sulfate content
of rat liver (Experiment 2)

Dietary
Sulfate%

Total Liver ulfate as % Body Weight
With Acetaminop en
Without Acetaminop en
X

10- 2

.02 (Diet B)

19.8 ± 1 _12,3,4,a b *
22.8 ± 1.2 ab*

.42 (Diet C)

17. 3

.0002 (Diet A)

± l. 0

b*

X

10- 2

1.2a *

20.2

±

19.6

± l. 2

19.4

±

a

*
0.5 a

l Acetaminophen administered 24 hours after Na 35 so = .
4
2
2Data are means± SEM of 5 male rats.
3values in
are significantly
4values on
are significantly

a column not followed by the same superscript letter
different (P < 0.05).
a line not followed by the same superscript symbols
different (P < 0.05).

TABLE 7
The effect of dietary inorganic sulfate and acetaminophen administration on the
total 35so = uptake in rat liver (Experiment 2)
4
35 so = Radioactivity in Dry Liver
4
With Acetaminophenl
Without Acetaminophen
q.,m/mg
cpm/mg
cpm/mg f body wt.
cpm/mg f bgdy wt.

Dietary
Sulfate %

X

lQ-6

X

9.8

±

l _82,3,4a*

25.3

±

.02 (Diet B)

16.6

±

3.8a*

44. 6

± l .6

a*

.42 (Diet C)

16. 2 ± l. 6 a*

44.2

± 4.l

ab*

.0002 (Diet A)

5.0 b*

15.2 ± 1.4
17.l± 1.9 a*
15.l ± 3.3 a*

10-

39.3 ± 4.0 a
45. 0 ± 5. 8a*
a*
40. 5 ± 9. 0

1Acetaminophen administered 24 hours after Na 35 so =.
4
2
2Data are means± SEM of 5 male rats.
3column values for identical computations not followed by same superscript letter are significantly
different (P < 0.05).
4Line values for identical computations not followed by the same superscript symbol are significantly different (P < 0.05).

w
w

TABLE 8
The effect of ~ietary inorganic sulfate and acetaminophen administration on the
total 3 so = uptake rat liver expressed as% dose (Experiment 2)
4

35 so~= Radio~ctivitv in Dry Liver as Expressed by% Dose
With Acet an;; nophen 1
Wfffiout Acetaminophen
t6fa-1 cprn +
cpm7mg
cpm7mg
total cpm +
dry liver wt.
wet l i vet wt.
dry liver wt.
wet liver wt.

Dietary
Sulfate%

X

.0002 (Diet
.02 (Diet

B)

. 42 (Diet C)

A)

10-2

X

10-b

± 3. o b*

19.0 ± 2.82,3,4a*

17.3

30.8 ± 6.3a*

28.6 ± 6. 3a*

27.5 ± 4.3 a*

27.l ± 3_ 6ab*

X

32. 5

10-l'.'.

± l .6

X

a

30.8 ± 3.8 a*
27.l ± 6.2 a*

l o-6

26.3 ± 2.4a
29. 5 ± 3. 6 a*
26. l ± 5. 6a*

1Acetaminophen given 24 hours after Na 35 so;.
2
2Data are means± SEM of 5 male rats.
3column values for identical computations not followed by the same superscript letter are significantly different (P < 0.05).
4Line values for identical computations not follm1Jed by the same superscript symbol are significantly different (P < 0.05).

w
+:>
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difference in 35 so 4= occurs in the acetaminophen group when rats fed a
diet containing 0.0002% level of inorganic sulfate plus methionine
supplementation are compared to rats fed the 0.02% level of inorganic
sulfate plus methionine diet.

This difference is seen when data are

expressed as total cpm + wet liver weight and cpm/mg +bodyweight with
the control group fed the 0.02% level of inorganic sulfate plus methionine, having the higher values.

It should be noted that rats in

experiment 2 were older and heavier than those in experiment l and in
some cases may have been suffering from murine pneumonia.
Experiment 3: 35 s-Methionine Injected Simultaneously With Acetaminophen
Administration
The effects of dietary inorganic sulfate, varying methionine
levels, and acetaminophen on liver 35 S-glutathione, and 35 s-cysteine
synthesized from 35 s-methionine and the recovery of 35 s-methionine
administered as a pulse dose are illustrated in Tables 9, 10, and 11
respectively. No dietary or drug differences can be detected for 35 s.
.
. d f rom 35 s -me th·1on1ne.
.
Th e data
an d 35 s -cys t e,ne
syn th es,ze
gl ut ath ,one
in Table 11 expressing 35s-methionine in the liver show a significant
difference in livers from rats treated with acetaminophen between those
livers from rats fed a diet containing 0.02% level of inorganic sulfate
with methionine supplementation and those fed a diet containing 0.0002%
inorganic sulfate with methionine supplementation with the latter having
higher values.

This difference is seen when data are expressed as%

dose, % dose+ liver weight, and% dose+ body weight.

A statistically

significant dietary difference is also detected in the livers from
control groups when data are expressed as% dose and is between rats fed
a diet containing 0.0002% inorganic sulfate with methionine
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TABLE 9
The effect of dietary inorganic sulfate on liver 35 s-glutathione
synthesized from 3~?-methionine after simultaneous
administration of
S-methionine and acetaminophen

Dietary
Sulfate %

With Acetaminophen
Without Acetaminophen
355 cpm in glutathione

.0002 (Diet A)
% dose x 10- 1
_
% dose f liver wt. x 1g 5
% dose f body wt. x 10 6

2.97 ± l.36!';' 3a*
2.64 ± 1.12 *
1.28 ± .57a

a*
3.46 ± 1.54a*
3.53 ± l. 72 *
3.42 ± 1. 81 a

.02 (Diet B) -l
% dose x 10
_
% dose f liver wt. x 10 5
% dose f body wt. x 10-6

1.35 ± .35a:
1.54 ± .40a *
. 64 ± . 18a

a*
. 81 ± .24a*
1. 01 ± .29 *
.41 ± . 14 a

. 42 (Di et C) - l
% dose x 10
_
% dose f liver wt. x 10 5
% dose f body wt. x 10-6

a **
2.62 ± 1.05a *
. 56 ± . 16a

a*
2.31 ± .60a*
1 .44 ± .48 *
.64 ± • 2ra
0

2. 31

±

. 85

1Data are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 10
35
The effect of dietary inor~anic sulfate on liver
s-cysteine
synthesized from 3 S-methionine after simultaneous
administration of 35s-methionine and acetaminophen

Dietary
Sulfate%
.0002 (Diet Al 2
_6
% dose x 10
% dose + 1i ver wt. x 10
% dose + body \'Jt. X 10-9

With Acetaminophen
Without Acetaminophen
35 S cpm 1n cyste1ne
5.79 ± 3.26:;2,3a*
5.33 ± 2. 91 *
2.60 ± 1 .48a

a*
15.23 ± 6.48a*
14. 43 ± 6.02 *
3.54 ± 2. 18a

.02 (Diet B) _
2
% dose x 10
-6
% dose+ 1i ver wt. X 10
9
% dose + body wt. X 10-

a*
.89 ± .23a*
.99 ± .24a*
.40 ± . 10

3.00 ± 1. 33 a*
~*
4.03 ± 1. 70;*
l .62 ± . 15

.42 (Diet C) _2
% dose x 10
6
% dose • liver wt. X 10% dose+ body wt. X 10-9

a*
3. 16 ± l.70a*
3.66 ± l. 99 *
l. 52 ± .82a

a*
. 61 ± . 14 a*
.74 ± .22 *
.27 ± .08a

1oata are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 11
The effect of dietary inorganic sulfate on live 35 35 s-methionine
recovery after simultaneous administration of S-methionine
and acetaminophen

Dietary
Sulfate%

With Acetaminophen
Without Acetaminophen
5s cpm in methionine

.0002 (Diet A)
% dose x 10-3
% dose+ liver wt. x 10 7
% dose+ body wt. x 10-

8.53 ± 1 . 37 1,2,3a*
a *
7.70 ± 1. 00 *
3.56 ± .57 a

c*
8.80 ± 1. 38a*
8.49 ± 1. 32 *
3.90 ± .73a

.02 (Diet B) _
% dose x 10 3
% dose+ liver wt. x 10~ 7
% dose+ body wt. x 10-

ab*
4.32 ± .88ab*
4.94 ± 5.33ab*
2.01 ± .42

d*
4.00 ± .60a*
5.33 ± 1. 22 a*
2.08 ± .43

.42 (Diet C)
% dose x 10- 3
% dose • 1i ver wt. x 1Q-7
% dose+ body Wt. X 10' 8

b*
6.00 ± 2.06b*
6.60 ± 2.1\*
2.95 ± 1. 18

d*
4.66 ± .69a*
5.25 ± 1. 26 *
2.03 ± .25a

8

1Data are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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supplementation and those fed 0.02% inorganic sulfate with methionine
supplementation.

A dietary difference is also seen between rats fed

diets containing 0.0002% inorganic sulfate with methionine supplementation compared to rats fed the diet containing 0.42% inorganic sulfate
without additional methionine.

Rats fed 0.0002% inorganic sulfate with
methionine supplementation have the higher 35 s-methionine values in both
comparisons.
Experiment 4: 35 s-Methionine Injected Three Hours Before Acetaminophen
Administration
The effects of dietary inorganic sulfate, varying levels of
methionine, and acetaminophen on liver 35 S-glutathione and liver 35 smethionine, when acetaminophen was administered three hours after a
pulse dose of 35s-methionine, are illustrated in Tables 12, 13, and 14,
respectively.

Dietary related statistically significant differences
were detected for 35 S-glutathione synthesized from 35 s-methionine in
livers of acetaminophen-treated animals.
expressed as% dose,% dose

f

These differences are

liver weight, and% dose

f

body weight

when comparing livers from rats fed a diet containing 0.0002% inorganic
sulfate plus methionine supplementation to those livers from rats fed
diets containing 0.42% inorganic sulfate without methionine supplementation.

Another dietary related statistically significant difference in

the acetaminophen-treated rats can be observed in data from Table 14 on
the recovery of 35 s-methionine. A statistically significant higher
value for 35 s-methionine is observed in livers from rats fed diets containing 0.0002% inorganic sulfate plus methionine supplementation and
0.02% inorganic sulfate plus methionine supplementation to those livers
from rats fed a diet containing 0.42% inorganic sulfate and no methionine
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TABLE 12
The effect of dietary inorganic sulfate on liver 35 s-glutathione
synthesized from 35s-methionine after administration of
acetaminophen 3 hours after 35s-methionine injection

Dietary
Sulfate%
With Acetaminophen
Without Acetaminophen
- - - - - - - - - - - - - - - - - : : s 5 s cpm in glutathione
. 0002 (Di et A)
% dose x 10-l
_
% dose+ liver wt. x 10 5
% dose+ body wt. x 10-7

1,2,3a*
5 . 82 ± 2 . 23 a*
2.50 ± .54 *
11.52 ± 2.60a

.02 (Diet B) -l
% dose x 10
_
% dose+ liver wt. x 10 5
% dose+ body wt. x 10-7

ab*
10.50 ± 3.59ab*
1 • 97 ± • 60 b*
9.10 ± 3.31a

a*
7.21 ± 3.60a*
4.40 ± 2.93 *
19.10 ± 5.63a

. 42 (Di et C) _ l
% dose x 10
_
% dose+ liver wt. x 10 5
% dose+ body wt. x 10- 7

b*
4.69 ± l .81b*
1.35 ± .24b*
5.38 ± .79

a*
4.61 ± 2.46a*
2.72 ± 1.36a*
11 . 10 ± 5. 56

a*
6.35 ± 3.79a*
l . 95 ± • 32 *
9.02 ± .94a

1oata are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 13
35
The effect of dietar~ inorganic sulfate on liver s-cysteine
synthesized from 5s-rnethioni~i after administration of
acetaminophen 3 hours after
S-methionine injection

Dietary
With Acetaminophen
Without Acetaminophen
Sulfate%
- - - - - - - - - - - - - - - - - - - - " \ 5 S cpm in cystei ne
.0002 (Diet A2 2
% dose x 10
6
% dose+ liver wt. X 10% dose+ body wt. X 10-8

4.80
4. 19
16.94

±
±
±

2 _57 a1;2,3a*
2.02a*
9.10

9.22
7. 12
31. 79

±
±
±

a*
4.22a*
3. 10 a*
13.74

.02 (Diet B) _
% dose x 10 2
6
% dose+ liver wt. x 10~
% dose 7 body wt. x 10-

12.43
10.10
47.63

±
±
±

a*
4.9la*
3.62 *
19.26a

8.31
6.84
25.34

±
±
±

a*
l. 95 a*
l. 18._*
8.67°

.42 (Diet C) _2
% dose x 10
-6
% dose • liver Wt. X 10
% dose 7 body Wt. X 10-8

3.37
2.67
12. 16

±
±
±

a*
l. 34 a*
.99 *
5.06a

9. 41
9. 13
37.33

±
±
±

a*
3.64a*
3.6la*
15.02

l Data are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 14
The effect of dietary inorganic sulfate on liver 35 s-methionine
recovery after adm1iistration of acetaminophen 3 hours after
S-methionine injection

Dietary
Sulfate%

~~i

th Acetaminophen
Without Acetaminophen
35 S cpm in methionine

.0002 (Diet All
% dose x 10
dose+ liver wt. X 10-S
% dose f body wt. X 10-8

11. 18
10.20
3. 77

±
±
±

2.401; 2 '3a*
a
2.39a*
.64

7.56
6.28
2.93

. 02 (Di et B) _l
% dose x 10
_5
% dose+ liver wt. x 10
% dose+ body wt. x 10-8

9.20
8. 12
3.55

±
±
±

a*
.98a*
l . 19 *
.47a

8.82 ± l . 16 a*
a*
7.64 ± l. 05 *
3.30 ± .47a

.42 (Diet C) -l
% dose x 10
5
% dose f liver wt. X 10% dose f body wt. X 10-8

b*
3.82 ± .78b*
3.64 ± .9lb*
1.40 ± .29

0/
/0

±
±
±

4.96 ±
4.50 ±
l.81 ±

a*
2. 10 a*
l . 83 a*
.84

a*
.59a*
.46 *
.2la

1Data are means± SEM of 5 male rats.
2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).

43
supplementation.

Dietary effects on 35 s-cysteine synthesized from 35 s-

methionine were not observed.

In all of the data expressing radioactiv-

ity, no statistically significant differences were seen between acetaminophen-treated rats and controls.
Experiment 5: 35 s-Cysteine Injected Simultaneously With Acetaminophen
Administration
The effects of dietary inorganic sulfate, varying levels of
methionine, and acetaminophen on the synthesis of 35 s-glutathione from
35 s-cysteine and recovery of 35 s-cysteine administered as a pulse dose
are illustrated in Tables 15 and 16. Dietary effects on the synthesis
of 35 s-glutathione from 35 s-cysteine (Table 15) in livers from rats fed diets
containing 0.02% inorganic sulfate plus methionine supplementation are
statistically difference from those livers from rats fed 0.42% inorganic
sulfate with no methionine supplementation when data are expressed as
% dose,% dose+ liver weight, and% dose+ body weight.

In addition

the livers from rats fed a diet containing 0.02% inorganic sulfate plus
methionine supplementation are statistically difference from those rats
fed 0.0002% inorganic sulfate plus methionine supplementation when data
are expressed as% dose and% dose+ body weight.

Dietary inorganic

sulfate and methionine supplementation did not statistically affect 35 scysteine recovery (Tablel6). The effect of acetaminophen can be observed on
the recovery of 35 S-glutathione from 35 s-cysteine when compared to controls
(Table 15).

Values for 35 S-glutathione synthesized from 35 s-cysteine in

livers from rats fed a diet containing 0.02% inorganic sulfate plus
methionine supplementation are higher for acetaminophen-treated rats
than control rats when data are expressed as% dose, % dose+ liver
weight, and% dose+ body weight.
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TABLE 15
The effect of dietary inorganic sulfate on liver 35 s-glutathione
synthesized from 3~ -cysteine after simultaneous administration
of
S-cysteine and acetaminophen

5

Dietary
Sulfate%

With Acetaminophen

Without Acetaminophen

- - - - - - - - - - - - - - - - - 3 5 5 cpm in glutathione

.0002 (Diet All
% dose x 10
5
% dose+ liver wt. X l 0% dose+ body wt. X 10-6
.02 (Diet B) -l
% dose x 10
_
% dose+ liver wt. x 10 5
% dose + body \1t. x l o-6
.42 (Diet C) - l
% dose x 10
liver wt. X 10- 5
% dose
% dose+ body wt. X 10-6

7.25
7.02
2.82

±
±
±

3.331,2,3!*
2.95 a; b
l. 30 a

b*
14. 01 ± 3.1\*
13. 12 ± 2.44b*
5. 19 ± 1.00
5.49
5.43
2. 15

±
±
±

-*

l . 46;*

l. 19 *
.59a

a*

l. 91 ± .28a*

2.56
l. 13

±
±

.25 *
. l oa

7.95
7.67
3.07

±
±

2.98a
2.84a
l. lOa

±

a*
4. 31 ± l. 28a*
5.27 ± 2.00_*
l. 98 ± .53°

l Data are means± SEM of 5 male rats.

2column values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 16
The effect of dietary inorganic sulfate on liver 35 s-cysteine recovery
after simultaneous administration of 35s-cysteine and acetaminophen

Dietary
Sulfate %
With Acetaminophen
- - - - - - - - - - - - - - - - - - 3 5 5 cpm
.0002 (Diet A)
_
% dose x 10-2
5
% dose~ liver wt. x 10
% dose~ body wt. x 20-7

7. 14
7.51
2.82

±
±
±

2.961},3a*
3.28:*
1. 19

,n

Without Acetaminophen
cysterne
6.47
5.49
2.40

±
±
±

a*
2.51 *
2.03a*
.87a

.02 (Diet B) _
2
% dose x 10
6
% dose -z- liver wt. X 10% dose -z- body wt. X 10-7

a*
12.69 ± 3.78a*
11. 72 ± 3.07 *
4.74 ± l . 31 a

13.87
13.34
5.55

±
±
±

a*
3.49a*
3.26 *
1. 40a

.42 (Diet C) _2
% dose x 10
% dose f liver wt. X 10-6
% dose -z- body wt. X 10-7

7.96 ± l. 40 a*
a*
7.86 ± l. 40 *
3.04 ± .60a

12.28
14.29
5.78

±
±
±

a*
l .78 *
3.24a
.55a

1oata are means ± SEM of 5 male rats.
2column values for identical computations not followed by the
saLle superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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Recovery of 35 5-cysteine (Table 16) detects a statistically
significant value for acetaminophen-treated rats, but no statistically
significant values are seen as a result of dietary manipulations.

The

acetaminophen-treated rats fed a diet containing 0.42% inorganic sulfate
with no additional methionine have a lower value for recovered 35 5cysteine expressed as% dose~ body weight when compared to controls.
Experiment 6: 35 5-Cysteine Injected Three Hours After Acetaminophen
Adm1nistrat1on
The effects of dietary inorganic sulfate, varying levels of
methionine, and acetaminophen on the synthesis of liver 35 5-glutathione
from 35 5-cysteine and recovery of 35 5-cysteine when acetaminophen was
administered three hours after 35 5-cysteine are illustrated in Tables 17
and 18, respectively.

Neither dietary inorganic sulfate level and varying levels of methionine supplementation nor did drug affect 35 5-glutathione biosynthesis from 35 5-cysteine. The only effect of dietary sulfate level on recovered 35 5-cysteine (Table 18) was in the acetaminophentreated groups. When data are expressed as% dose, the liver 35 5cysteine value was higher from livers of rats fed a diet containing
0.02% inorganic sulfate plus methionine supplementation than for those
livers from rats fed a diet containing 0.42% inorganic sulfate with no
additional methionine.

No differences were observed between the

acetaminophen-treated groups and controls in the synthesis recovery of
35 5-cysteine.
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TABLE 17
35
The effect of dietary iQorganic sulfate on liver
S-glutathione
synthesized from 3°s-cysteine after administration of
acetaminophen 3 hours after 35s-cysteine injection

Dietary
Sulfate %
With Acetaminophen
Without Acetaminophen
- - - - - - - - - - - - - - - - - - 3 5 5 cpm in glutathione
.0002 (Diet A~
% dose x 10
-3
% dose+ liver wt. X 10
5
% dose+ body wt. X 10-

1.17 ± 0. rn1; 2 , 3a*
l. 28 ± 0. 24\
4.97 ± 0.76a

4.70 ± l . 85 a*
a*
3.44 ± .87 *
19. 14 ± 7.70a

.02 (Diet 8) l
% dose x 10
% dose+ liver wt. X 10:3
% dose+ body wt. X 10-~

a*
3.06 ± l.23a*
4.27 ± l. 93 *
15.05 ± 6.39a

a*
8.97 ± 4.22a*
8.20 ± 3.30 *
31. 14 ± 16.32a

.42 (Diet C) l
% dose x 10
3
% dose • liver wt. X 10% dose+ body wt. X 10-5

.95 ± 0. 06 a**
1.04 ± 0. 70\
4.47 ± 0.4la

a*
5.87 ± 2. 17a*
6.75 ± 2.19a*
26. l 0 ± 9.29

1Da"i:a are means ± SEM of 5 male rats.
2column values for identical computations by the same superscript
letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).
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TABLE 18
The effect of dietary inorganic sulfate on liver 35 s-cysteine recovery
after administration of acetaminophen 3 hours after 35s-cysteine

Dietary
Sulfate%
With Acetaminophen
Without Acetaminophen
- - - - - - - - - - - - - - - - - - 3 5 S cpm in cystei ne
.0002 (Diet A)
_
% dose
% dose+ liver wt. x 19 4
% dose f body wt. x 10 5

4.47 ± 1 . 72 al ,2,3ab*
*
4.57 ± 1.96 *
1.83 ± .70a

1.83 ±
1. 71 ±
.76 ±

.02 (Diet B)
_
% dose
% dose f liver wt. x 1Q 54
% dose+ body wt. x 10

8.08 ± 2.76aa **
9. 14 ± 3.37 *
3.59 ± 1. 23a

5.55 ± 2. 77 a*
a*
4.92 ± 2.03 *
2.17 ± 1 . 01 a

.42 (Diet C)
% dose
% dose+ liver wt. X 1Q5-4
% dose+ body wt. X 10

3.61 ± 1 . 40 b*
a*
3.79 ± 1 .40 *
1.62 ± .60a

3.44 -+: 1 . 89 a*
a*
4.75 ± 2.99 *
1.60 ± .87a

a*
.52a*
.52a*
. 21

1Data are raeans ± SEJvi of 5 male rats.
2colu~n values for identical computations not followed by the
same superscript letter are significantly different (P < 0.05).
3Line values for identical computations not followed by the same
superscript symbol are significantly different (P < 0.05).

CHAPTER V
DISCUSSION
The dietary importance of inorganic sulfate in the diet of the
monogastric animal has been established in this laboratory (1).

The

importance of sulfur amino acids and inorganic sulfate in acetaminophen's :netabolism, treatment and protection from hepatotoxicity is well
documented (16, 20, 21, 22, 25, 67).

The relationships between sulfur

amino acids and inorganic sulfate outlined in fig. 2, p. 10, indicate how many
variables altering the sulfur amino acids can affect availability and/or
demand for inorganic sulfate and therefore possibly affect the metabolism of acetaminophen. Sodium 35 so 4= was administered to label ester
sulfate, 35 s-cysteine was administered to label ester sulfates and
neutral sulfur compounds other than methionine, and 35 s-methionine was
administered to label ester sulfates, neutral sulfates, and--by a precursor relationship--give an indication of the effect acetaminophen may
have on the remethylation pathway.

By administering these iostopes with

acetaminophen and in some experiments administering the isotopes prior
to the drug, interrelationships of how acetaminophen would affect
synthesis of sulfur containing compounds as well as affect tissue sulfur
were investigated.

The discussion, therefore, will be divided into

three sections according to the labeled compound given the rats, i.e.,
35 s-sulfate, 35 s-methionine, and 35 s-cysteine.
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so
35 S-Sulfate
In reviewing the data expressed as total liver sulfate as% body
weight (Table 3, page 28), a statistically significant decrease in total
liver sulfur as sulfate was observed in the lower values for total liver
sulfur as sulfate in the acetaminophei;-treated groups when compared to the
control groups in those rats fed diets containing 0.0002% and 0.02% inorganic sulfate and additional methionine.

Although a statistically signif-

icant difference cannot be seen in the 0.42% level of inorganic sulfate
and no methionine supplementation, a lower total sulfur as sulfate value
is seen in the drug-treated group.

An additional observation from Table 3

is that values for total liver sulfate as% body weight for acetaminophentreated rats show little variation between the different diets.

These

data suggest that in the acetaminophen-treated rats liver sulfate is
lowered to some constant level at which sulfate conjugation becomes
rate limiting.

This interpretation of these data is in agreement with

the suggestion by Wiertering et al. (14) that the Km for the formation
of PAPS is high and that this high Km limits the amount of sulfation
which can occur; therefore, high levels of acetaminophen will be
glucuronidated or lead to the formation of N-acetyl-p-benzoquinone by the
mixed function oxidase system in preference to conjugation with sulfate.
In the control group fed the 0.42% level of inorganic sulfate
with no additional methionine the total liver sulfate as% body weight
is lower than in the group fed a diet containing 0.02% inorganic sulfate
and methionine supplementation and significantly lower from the control
group fed 0.0002% level of inorganic sulfate with methionine supplementation.

These data suggest that the 0.42% inorganic sulfate diet not

supplemented with methionine will cause an adverse effect on the rats'
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Smith 8 in unpublished data demonstrated a similar

total sulfur status.

phenomenon with respect to the level of inorganic sulfate in the liver
of rats fed 0.0002, 0.02, 0. l, and 0.42% of inorganic sulfate with
decreasing methionine supplementation as inorganic sulfate was increased
to keep the total sulfur as sulfate constant at 0.67%.

These data

showea that those rats fed a diet containing 0.42% of inorganic sulfate
and no methionine supplementation have decreased liver sulfate compared
to those rats fed the diet containing 0. 1% of sulfate.

Since Michels

and Smith (5) had previously shown that inorganic sulfate is absorbed
across the gastrointestinal tract, the decreased level and apparent
availability of sulfate in the livers of rats fed those diets containing 0.42% of inorganic sulfate without additional methionine may reflect
a limit in the liver's ability to extract sulfate from the portal system. The 35 so 4= radiation values support Smith's theory (Tables 4 and
5, pages 29 and 30). When 35 so 4= is expressed as cpm/mg x dry liver
weight and total cpm

wet liver weights, rats treated with acetaminophen have significantly lower values for 35 so 4= when compared to
control rats.
~

The data in experiment 2--although internally inconsistent with
those of experiment 1--differ
ment l.

in several respects to data in experiFirst, the rats in experiment 2 had been given the 35 S-sulfate

27 hours before sacrificing rather than 3 hours; secondly, they were

older; and thirdly, some were expressing murine pneumonia which was not
in remission.

Therefore, since age, weight, and health affect drug

metabolism, these data would not be expected to support those data in
8John T. Smith (personal communication).
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which acetaminophen and 35 so 4= were given simultaneously (18, 22, 48,
68).
35 s-1Me th.1 onrne
.
The data collected when rats are given 35 s-~ethionine best
support earlier observations of Smith et al. that there is a sparing
effect on methionine when rats are fed the optimal level (0.02%) of
inorganic sulfate (7). In reviewing the values for 35 S-glutathione
synthesized from methionine, 35 s-cysteine synthesized from methionine,
and recovery of 35 s-methionine in acetaminophen-treated rats fed the
0.02% inorganic sulfate plus methionine, Tables 9, 10, and 11 on pages
36, 37, and 38 respectively, one can note lower 35 s-sulfur values
compared to the diets lower and higher in organic sulfate. These lower
35 s-sulfur values for the acetaminophen-treated group, although not
statistically significant, signify a trend which can be interpreted that
the 35 s-sulfur is more available for detoxication purposes at this level.
This assumption is supported by the values for 35 S-glutathione and 35 scysteine synthesized from 35 s-methionine given three hours prior to
acetaminophen as seen in Tables 12 and 13, pages 40 and 41, respectively.
Since this experiment was designed to evaluate acetaminophen's effect on
tissue stores, the higher 35 s-sulfur values of the livers from rats fed
a diet containing 0.02% inorganic sulfate plus methionine indicate that
the 35 S-glutathione and 35 s-cysteine synthesized from 35 s-methionine were
made more available for detoxication purposes than the other two diets.
Table 10 on page 37 illustrating 35 s-cysteine synthesized from
35 s-methionine, also reflects some information concerning the control
rats fed a diet containing 0.42% inorganic sulfate with no additional
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methionine.

In rats fed the lower levels of inorganic sulfate plus

methionine, acetaminophen-treated rats always have the lower values for
35 s-cysteine synthesized from 35 s-methionine, whereas in rats fed a
diet containing 0.42% inorganic sulfate with no additional methionine
the values for 35 S-glutathione synthesized from 35 s-methionine are
higher.

Smith (l) earlier stated that sulfate could inhibit the conver-

sion of cysteine to sulfate.

Taking this statement one step further,

by sparing cysteine sulfate could have the potential to inhibit the conversion of methionine to cysteine--thus accounting for the lower 35 s
activity in the cysteine isolated from the control group fed a diet
containing 0.42% inorganic sulfate with no methionine supplementation.
The trend higher values for 35 s-cysteine synthesized from 35 smethionine for the acetaminophen-treated group for the diet containing
0.42% inorganic sulfate with no additional methionine indicate that the
acetaminophen caused a stress which required that more 35 s-methionine be
used for synthesizing 35 s-cysteine which is ultimately available for
detoxifying acetaminophen.
In comparing Tables 12, 13, and 14 on pages 40, 41, and 42 for
values 35 s-glutathione synthesized from 35 s-methionine and recovery of
35 s-methionine, a trend is noted which would indicate that methionine is
drawn out of the remethylation pathway when the drug is administered.
Higher values for 35 s-methionine in controls when rats were fed a diet
containing 0.02% inorganic sulfate plus additional methionine and the
subsequent high values for the recovered 35 S-glutathione synthesized
from methionine, and 35 s-cysteine synthesized from methionine in the
acetaminophen-treated rats fed on the 0.02% inorganic sulfate plus
methionine diet illustrate 35 s-methionine is being pulled out of the
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remethylation pathway. In order words, more 35 s-methionine is being
incorporated into 35 s-glutathione for detoxification purposes. The
reason methionine would come out of the remethylation pathway is to
provide the sulfur for GSH synthesis for acetaminophen detoxification.
The higher values for 35 s-methionine recovery (Table 14, page 42) in
acetaminophen-treated rats suggest that rats which are fed diets containing 0.0002%inorganic sulfate plus additional methionine and 0.02%
inorganic sulfate with additional methionine keep more methionine in the
liver for potential mobilization to GSH sulfur.
A recent investigation by Smith9 supports the theory that methionine is being drawn out of the remethylation pathway as well as an
explanation why only trends are observable in several of the experiments
in this investigation. After giving Sprague Dawley rats_ l- 14 c-methionine,
expired 14 co 2 was measured in simultaneous acetaminophen-treated and
control groups for a period of two hours. An increased expiration of
14 co in the acetaminophen-treated rats when compared to the control
2
rats was found. It addition, it was observed that this increased 14 co 2
expiration as a result of drug treatment, is more apparent in the first
hour of metabolism.

Since the data reported here were collected three

hours after drug administration, the most active portion of acetaminophen conjugation was missed and only a trend remained.
35 s-Cysteine
The data collected from rats injected with 35 s-cysteine give a
clearer understanding of the effects of inorganic sulfate and methionine
9John T. Smith (personal communication).
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supplementation on the detoxication of acetaminophen. All four tables
reflecting the metabolism of rats given 35 s-cysteine (Tables 15, 16, 17,
and 18 on pages 44, 45, 47, and 48) illustrate that those rats fed the
optimal level of inorganic sulfate (0.02%) had greater 35 s-activity in
both cysteine recovered and glutathione synthesized than rats fed diets
containing either of the other two levels of sulfate. The higher
values for liver 35 S-glutathione synthesized from 35 s-cysteine shown in
Table 15 on page 44 are very illustrative in showing the effect of diet
and drug on sulfur metabolism. These higher 35 S-glutathione values for
glutathione synthesized from 35 s-cysteine demonstrate that 35 s-cysteine
is needed for detoxification of acetaminophen and therefore is being
pulled from the tissues for detoxication. The statistically significant
values of 35 S-glutathione synthesized from 35 s-cysteine between rats
treated with acetaminophen and controls are seen when rats are fed the
diet containing 0.02% inorganic sulfate plus methionine as with the
drug-treated group having the higher values. The same trend of high
35 s-cysteine values for livers from rats fed the diet containing 0.02%
inorganic sulfate plus additional methionine is seen in the other livers
of rats fed the other two diets when comparing acetaminophen-treated to
controls.

These statistically significant dietary differences manifest

themselves when comparing rats fed a diet containing 0.0002% inorganic
sulfate plus methionine and a diet containing 0.42% inorganic sulfate
with no methionine supplementation to rats fed the optimal diet of
0.02% inorganic sulfate plus additional methionine. This supports earlier
evidence that 0.02% inorganic sulfate is the optimal level for the rat
(7).

These comparisons are statistically significant when comparing

rats fed the diet containing 0.02% inorganic sulfate plus methionine
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supplementation, to the 0.0002% inorganic sulfate plus methionine
supplementation when recovered 35 5-glutathione synthesized from 35 5methionine is expressed as% dose and% dose liver weight (Table 15,
page 44) and when compared to rats fed 0.42% inorganic sulfate plus no
methionine supplementation when recovered 35 5-glutathione synthesized
from 35 5-methionine is expressed as% dose, ~%dose~ liver weight,
and% dose~ body weight.
Table 15, page 44, illustrates the 35 5-glutathione values synthesized from 35 5-cysteine after a simultaneous administration of 35 5cysteine and acetaminophen, and--as discussed previously--reflect
statistically significant differences in regards to the effects of
acetaminophen administration and varying levels of inorganic sulfate
and methionine. Table 9, page 36, illustrates the values of liver 35 5glutathione synthesized from 35 5-methionine after a simultaneous injection of acetaminophen and shows no statistical significance regardless
to drug treatment or the various diets. The reason values for 35 5glutathione synthesized from cysteine show significant differences with
respect to drug administration and the various diets in comparison to
the values of 35 5-glutathione synthesized from methionine is that
cysteine is metabolically closer to G5H than methionine.

Methionine

compared to cysteine also has many more metabolic fates (fig. 2, page
11 ) .

Other useful information obtained was the fact that the time
after the drug was administered to the time the liver was removed for
analyzing was possibly too long of a time period to measure the effects
which acetaminophen may have on sulfur metabolism.

Since in some

experiments only trends were seen, an earlier sacrificing time could
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yield more evidence to further support the importance of inorganic
sulfur and sulfur sources in the detoxication of acetaminophen.
research is warranted in this area.

Further

CHAPTER VI
SUMMARY

The interrelationship between methionine and inorganic sulfate
affecting availability and/or demand for sulfur nucleophiles needed for
detoxicating acetaminophen was investigated. A pulse dose of 7 µCi of
35 so = was administered to label ester sulfates and livers were analyzed
4
for total liver sulfur as sulfate and radioactivity. A pulse dose of
7 µCi of 35 s-cysteine was administered to label 35 S-glutathione synthesized from 35 s-cysteine as well as the recovery of 35 s-cysteine.

To

evaluate the effect acetaminophen and varying levels of inorganic
sulfate and methionine may have on 35 s-methionine being drawn from the
remethylation pathway, a pulse dose of 7 µCi of 35 s-methionine was
35 s -me th.,onrne,
35 s -g 1ut a"'-1--h.,,one, an d
. . . t ere d . Bya dminis
. . t er,ng
.
.
aamrn,s
35 s -cys t e1ne
·
. . f rom 35 s -me th'1on1ne
.
syn th es1zect
as we 11 as th e recovery
of 35 s-methionine was determined. These isotopes were administered in
certain experiments simultaneously with acetaminophen (75 mg acetaminophen/kg body weight); the rats were sacrificed three hours later to
evaluate the effect on liver synthesis of sulfur compounds.

The isotopes

were also administered prior to acetaminophen administration to ascertain the effect acetaminophen would have on tissue sulfur compounds.
35 so = was given
..
.
24 hours prior
. t o acetam,nop
. .
hen an d 35 s Soa,um
4
methionine and 35 s-cysteine three hours prior to acetaminophen administration.
The data from the rats given 35 so 4= simultaneously with acetaminophen indicate that in the acetaminophen-treated rats, liver sulfate is
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lowered to some constant level at which sulfate conjugation becomes
rate limiting.

The data also suggest that high levels of acetaminophen

will be glucuronidated or metabolized by P-450 enzymes in preference to
conjugation with sulfate.
Data from rats given 35 s-methionine indicate that there is an
increased need for cysteine and that since sulfate can spare the conversion of cysteine sulfur to sulfate it could also spare the conversion of
35 s-methionine to 35 s-cysteine. There is an indication of a trend that
35 s -me th·1on1ne
. may be pu 11 ed f rom th e reme th ya
l t·10n pa t nway t o f orm
1

35 s-glutathione thus facilitating acetaminophen detoxification.

Data also

support previous researchers who demonstrated that 0.02% of tnorganic
sulfate is the optimal level for the diet of the monogastric animal.
The data collected from livers of rats given the pulse dose of
35 s-cysteine supply evidence that cysteine is being pulled from tissue
stores for detoxication of acetaminophen.

This investigation stresses

the importance of dietary inorganic sulfate as well as methionine in
detoxification of a pulse dose of acetaminophen.
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